Harrow Health, Inc. Forecast, price target & analysts
Harrow Health, Inc. Target price 2025 - Analyst rating & recommendation
Harrow Health, Inc. Classifications & Recommendation:
Harrow Health, Inc. Price Target
| Target Price | $57.88 |
| Price | $27.56 |
| Potential |
110.02%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Harrow Health, Inc. 2026 .
The average Harrow Health, Inc. target price is $57.88.
This is
110.02%
register free of charge
$69.00
150.36%
register free of charge
$50.40
82.87%
register free of charge
|
|
| A rating was issued by 5 analysts: 5 Analysts recommend Harrow Health, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harrow Health, Inc. stock has an average upside potential 2026 of
110.02%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 130.19 | 191.18 |
| 46.94% | 46.85% | |
| EBITDA Margin | 9.92% | 16.86% |
| 60.45% | 69.89% | |
| Net Margin | -20.51% | -12.44% |
| 0.08% | 39.36% |
5 Analysts have issued a sales forecast Harrow Health, Inc. 2024 . The average Harrow Health, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Harrow Health, Inc. EBITDA forecast 2024. The average Harrow Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Harrow Health, Inc. Analysts have issued a net profit forecast 2024. The average Harrow Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.75 | -0.67 |
| 47.06% | 10.67% | |
| P/E | negative | |
| EV/Sales | 5.78 |
5 Analysts have issued a Harrow Health, Inc. forecast for earnings per share. The average Harrow Health, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Harrow Health, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Harrow Health, Inc....
Current Harrow Health, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Feb 06 2025 |
| Craig-Hallum | Locked ➜ Locked | Locked | Oct 04 2024 |
| Lake Street | Locked ➜ Locked | Locked | Oct 04 2024 |
| B. Riley Securities | Locked ➜ Locked | Locked | Aug 29 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Feb 06 2025 |
|
Locked
Craig-Hallum: Locked ➜ Locked
|
Oct 04 2024 |
|
Locked
Lake Street: Locked ➜ Locked
|
Oct 04 2024 |
|
Locked
B. Riley Securities: Locked ➜ Locked
|
Aug 29 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
